X-100406898-G-C

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001184880.2(PCDH19):ā€‹c.1700C>Gā€‹(p.Pro567Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,209,743 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00014 ( 0 hom., 4 hem., cov: 23)
Exomes š‘“: 0.0000073 ( 0 hom. 2 hem. )

Consequence

PCDH19
NM_001184880.2 missense

Scores

1
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 8.14
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.25266248).
BP6
Variant X-100406898-G-C is Benign according to our data. Variant chrX-100406898-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 515827.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000143 (16/111619) while in subpopulation AFR AF= 0.000521 (16/30699). AF 95% confidence interval is 0.000327. There are 0 homozygotes in gnomad4. There are 4 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PCDH19NM_001184880.2 linkuse as main transcriptc.1700C>G p.Pro567Arg missense_variant 1/6 ENST00000373034.8 NP_001171809.1
PCDH19NM_001105243.2 linkuse as main transcriptc.1700C>G p.Pro567Arg missense_variant 1/5 NP_001098713.1
PCDH19NM_020766.3 linkuse as main transcriptc.1700C>G p.Pro567Arg missense_variant 1/5 NP_065817.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PCDH19ENST00000373034.8 linkuse as main transcriptc.1700C>G p.Pro567Arg missense_variant 1/61 NM_001184880.2 ENSP00000362125 A1Q8TAB3-1
PCDH19ENST00000255531.8 linkuse as main transcriptc.1700C>G p.Pro567Arg missense_variant 1/51 ENSP00000255531 P5Q8TAB3-2
PCDH19ENST00000420881.6 linkuse as main transcriptc.1700C>G p.Pro567Arg missense_variant 1/51 ENSP00000400327 A1Q8TAB3-3

Frequencies

GnomAD3 genomes
AF:
0.000143
AC:
16
AN:
111565
Hom.:
0
Cov.:
23
AF XY:
0.000118
AC XY:
4
AN XY:
33801
show subpopulations
Gnomad AFR
AF:
0.000522
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000440
AC:
8
AN:
181656
Hom.:
0
AF XY:
0.0000148
AC XY:
1
AN XY:
67498
show subpopulations
Gnomad AFR exome
AF:
0.000645
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000729
AC:
8
AN:
1098124
Hom.:
0
Cov.:
32
AF XY:
0.00000550
AC XY:
2
AN XY:
363478
show subpopulations
Gnomad4 AFR exome
AF:
0.000303
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.000143
AC:
16
AN:
111619
Hom.:
0
Cov.:
23
AF XY:
0.000118
AC XY:
4
AN XY:
33865
show subpopulations
Gnomad4 AFR
AF:
0.000521
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000219
ExAC
AF:
0.0000495
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 9 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 03, 2023This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 567 of the PCDH19 protein (p.Pro567Arg). This variant is present in population databases (rs201989363, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. ClinVar contains an entry for this variant (Variation ID: 515827). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PCDH19 protein function. Experimental studies have shown that this missense change affects PCDH19 function (PMID: 34082468). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 09, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
PCDH19-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 19, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
0.0028
T
BayesDel_noAF
Uncertain
0.13
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.071
.;T;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D;D;D
M_CAP
Uncertain
0.16
D
MetaRNN
Benign
0.25
T;T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.1
L;L;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.7
N;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.032
D;T;D
Sift4G
Benign
0.066
T;T;T
Polyphen
1.0, 0.96
.;D;D
Vest4
0.68
MVP
0.69
MPC
1.3
ClinPred
0.13
T
GERP RS
5.8
Varity_R
0.34
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201989363; hg19: chrX-99661896; API